510(k) Report

510(k) · Cleared

Cleared

cobas CTNG for use on cobas 6800/8800 systems

K202408510(k) TraditionalCleared Jan 21, 2021153-day reviewClass II21 CFR 866.3393

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Molecular Systems, Inc. · QEP Nucleic Acid Detection System For Non-Viral Microorganism (S) Causing Sexually Transmitted Infections

Cleared on Jan 21, 2021 as substantially equivalent to K173887 (Roche Molecular Systems, Inc., 2018) after a 153-day review. Its family tree reaches back 7 generations to 2001. 3 later devices descend from it.

Decided
Jan 21, 2021
Review
153 days
Class
Class II
Product code
QEP
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K003395 (2001). 14 ancestors in all, the oldest P950039 (1996). 3 later devices descend from it, 3 citing it directly.

  1. Root · 7 generations backK003395 Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc. · 2001 · Recalled
  2. 6 generations backK081825 BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO · 2008 · Recalled
  3. 5 generations backK091724 BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO · 2009
  4. 4 generations backK110923 Cobas 4800 CT / NG TestRoche Molecular Systems, Inc. · 2012 · Recalled
  5. 3 generations backK132270 Cobas CT/NG V2.0 TestRoche Molecular Systems, Inc. · 2013
  6. 2 generations backK163184 cobas® CT/NG v2.0 TestRoche Molecular Systems, Inc. · 2017
  7. 1 generation backK173887 cobas CT/NG for use on cobas 6800/8800 systemsRoche Molecular Systems, Inc. · 2018
  8. This deviceK202408 cobas CTNG for use on cobas 6800/8800 systemsRoche Molecular Systems, Inc. · 2021
  9. Descendant · cites it directly · 0 of its ownK260917 cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG…Roche Molecular Systems, Inc. · 2026
  10. Descendant · cites it directly · 0 of its ownK253759 cobas liat CT/NG/MG nucleic acid testRoche Molecular Systems, Inc. · 2026
  11. Descendant · cites it directly · 0 of its ownK253756 cobas liat CT/NG nucleic acid testRoche Molecular Systems, Inc. · 2026

Most influential descendants

Showing 3 of 3 · See all
  • K260917cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the…Roche Molecular Systems, Inc. · 2026 · cites it directly0descendants
  • K253759cobas liat CT/NG/MG nucleic acid testRoche Molecular Systems, Inc. · 2026 · cites it directly0descendants
  • K253756cobas liat CT/NG nucleic acid testRoche Molecular Systems, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K003395Gen-Probe Aptima Combo 2 AssayGen-Probe, Inc.20011
−6K081825BD Probetec Neisseria Gonorrhoeae (GC) Q Amplified Dna AssayBecton, Dickinson & CO20081
−5K091724BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna AssayBecton, Dickinson & CO2009—
−4K110923Cobas 4800 CT / NG TestRoche Molecular Systems, Inc.20122
−3K132270Cobas CT/NG V2.0 TestRoche Molecular Systems, Inc.2013—
−2K163184cobas® CT/NG v2.0 TestRoche Molecular Systems, Inc.2017—
−1K173887cobas CT/NG for use on cobas 6800/8800 systemsRoche Molecular Systems, Inc.2018—
0 (this device)K202408cobas CTNG for use on cobas 6800/8800 systemsRoche Molecular Systems, Inc.2021—
+1K260917cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use…Roche Molecular Systems, Inc.2026—
+1K253759cobas liat CT/NG/MG nucleic acid testRoche Molecular Systems, Inc.2026—
+1K253756cobas liat CT/NG nucleic acid testRoche Molecular Systems, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200110
200510
200620
200910
201010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202630
FIG. 1 — Lineage of K202408, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QEP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QEP device

  1. #1 K260917 cobas CT/NG for use on the cobas…score 13.7 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K173887cobas CT/NG for use on cobas 6800/8800 systems
Summary page 4
…LSL: Sec. 866.3390 OOI: Sec. 862.2570 Predicate Devices cobas® CT/NG for use on the cobas® 6800/8800 systems (K173887) Establishment Registration Roche Molecular Systems, Inc. (2243471)…
Roche Molecular Systems, Inc.2018—

Also cleared against K173887: 2 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260917cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the…Roche Molecular Systems, Inc.20260
K253759cobas liat CT/NG/MG nucleic acid testRoche Molecular Systems, Inc.20260
K253756cobas liat CT/NG nucleic acid testRoche Molecular Systems, Inc.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • 5 of the 14 ancestors have a recall of any class.
  • Of its descendants, K260917 (Roche Molecular Systems, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K173887.

How does its category compare?

All QEP devices

QEP Nucleic Acid Detection System For Non-Viral Microorganism (S) Causing Sexually Transmitted Infections: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QEP

4in 2025

2019: 52020: 32021: 32022: 32023: 32025: 42026 (partial year): 3
2007high 5 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QEP

268in 2025

2019: 85 days median2020: 46 days median2021: 521 days median2022: 438 days median2023: 325 days median2025: 268 days median2026 (partial year): 171 days median
2007high 521 (2021) · low 46 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QEP

3in 2024

2024: 3
2007high 3 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QEP

9in 2025

2021: 12022: 12023: 82024: 82025: 9
2007high 9 (2025) · low 0 (2007)2025

MAUDE reports naming product code QEP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
201958500
202034600
2021352101
2022343801
2023332508
20240—38
2025426809
202631710—

What is it indicated for?

The cobas® CT/NG for use on the cobas® 6800/8800 Systems is an automated, qualitative in vitro nucleic acid diagnostic test, that utilizes real-time polymerase chain reaction (PCR), for the direct detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) DNA in male and female urine, clinician-instructed self-collected vaginal swab specimens (collected in a clinical setting), and clinician-collected vaginal swab specimens, endocervical…

Read the full statement (339 words)

The cobas® CT/NG for use on the cobas® 6800/8800 Systems is an automated, qualitative in vitro nucleic acid diagnostic test, that

utilizes real-time polymerase chain reaction (PCR), for the direct detection of Chlamydia trachomatis (CT) and/or Neisseria

gonorrhoeae (NG) DNA in male and female urine, clinician-instructed self-collected vaginal swab specimens (collected in a clinical

setting), and clinician-collected vaginal swab specimens, endocervical swab specimens, oropharyngeal (throat) swab specimens and

anorectal swab specimens all collected in cobas® PCR Media (Roche Molecular Systems, Inc.), and cervical specimens collected in

PreservCyt® Solution. This test is intended as an aid in the diagnosis of chlamydial and gonococcal disease in both symptomatic and

asymptomatic individuals.

Ancillary Collection Kits

The cobas® PCR Media Dual Swab Sample Kit is used to collect and transport human specimens. The cobas® PCR Media serves as

a nucleic acid stabilizing transport and storage medium.

Note: This kit has been validated for use with the following tests:

• cobas® CT/NG v2.0 Test (for use on the cobas® 4800 Systems)

• cobas® CT/NG for use on cobas® 6800/8800 Systems

• cobas® TV/MG for use on the cobas® 6800/8800 Systems

The cobas® PCR Media Uni Swab Sample Kit is used to collect and transport human specimens. The cobas® PCR Media serves as

a nucleic acid stabilizing transport and storage medium.

Note: This kit has been validated for use with the following tests:

• cobas® CT/NG v2.0 Test (for use on the cobas® 4800 Systems)

• cobas® CT/NG for use on cobas® 6800/8800 Systems

• cobas® TV/MG for use on the cobas® 6800/8800 Systems

• cobas® Cdiff Test for use on the cobas® 4800 System

The cobas® PCR Urine Sample Kit is used to collect and transport urine specimens. The cobas® PCR Media serves as a nucleic acid

stabilizing transport and storage medium.

Note: This kit has been validated for use with the following tests:

• cobas® CT/NG v2.0 Test (for use on cobas® 4800 Systems)

• cobas® CT/NG for use on cobas® 6800/8800 Systems

• cobas® TV/MG for use on the cobas® 6800/8800 Systems

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K202408: cobas CTNG for use on cobas 6800/8800 systems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K202408

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026